x

¿Aún no está registrado?

Cree su cuenta. Regístrese en Elsevier y obtendrá: información relevante, máxima actualización y promociones exclusivas.

Registrarme ahora
Ayuda - - Regístrese - Teléfono 902 888 740
Buscar en

FI 2016

1,042
© Thomson Reuters, Journal Citation Reports, 2016

Indexada en:

Index Medicus/Medline, Excerpta Medica/EMBASE, IBECS, IME, SCOPUS, Medes, Science Citation Index Expanded.

Métricas

  • Factor de Impacto: 1,042(2016)
  • 5-años Factor de Impacto: 0,989
  • SCImago Journal Rank (SJR):0,24
  • Source Normalized Impact per Paper (SNIP):0,583

© Thomson Reuters, Journal Citation Reports, 2016

Aten Primaria 2001;27:663-6 - DOI: 10.1016/S0212-6567(01)78877-4
Asistencia farmacéutica a la prescripción para aproximar la práctica clínica a la evidencia científica
Attention to pharmaceutical prescriptions to bring clinical practice into line with scientific evidence
E.J. Alegre del Rey, , L. Martínez Rodríguez, I. Tejedor de la Asunción, A. Rabadán Asensio
Distrito Bahía-Cádiz de Atención Primaria. Unidad de Farmacia
Aceptado 05 febrero 2001
Resumen
Objective

The objective of this study is to assess the usefulness of a programme of attention to pharmaceutical prescriptions (APP) so as to detect medicine-related problems.

Design

A descriptive study of the findings after six months operation of this programme.

Setting

Five primary care centres in the Bahía-Cádiz Area.

Patients

All the patients (499) who requested advice on their drug therapy and were included at the request and on the criterion of their doctor were studied.

Intervention

We introduced the APP programme for chronic patients, with two basic aims:

1. Care: to detect medicine-related problems and propose individual solutions.

2. Teaching: to bring drug-therapy skills used in clinical practice into line with the scientific evidence available.

Measurements and results

We focused on the detection of problems related to the most common medicines, with direct and relevant incidence on morbidity and mortality. We detected 236 cases (47%) of possible therapeutic improvement that had important implications for associated morbidity, of which 114 (23%) also had implications for mortality. 56% of the patients took more than 4 medicines, multiple medication that could easily be reduced in 43.5% of cases, so avoiding the use of medicines of low intrinsic value.

Conclusions

The programme was very useful, as numerous very clinically relevant problems were detected and information was gained that the doctor can use to bring drug therapy into line with the available scientific evidence.

Palabras clave
Farmacoepidemiología, Utilización de medicamentos, Problemas relacionados con medicamentos, Interacciones de fármacos, Polimedicación
Key words
Drug epidemiology, Use of medicines, Medicine-related problems, Drug interactions, Multiple medication
El Texto completo solo está disponible en PDF
Bibliografía
1.
R. Delgado Vila
La variabilidad de la práctica clínica
Rev Calidad Asistencial, 11 (1996), pp. 177-183
2.
C. Salisbury,N. Bosanquet,E. Wilkinson,A. Bosanquet,J. Hasler
The implementation of evidence-based medicine in general practice prescribing
Br J Gen Prac, 48 (1998), pp. 1849-1851
3.
J. Rey Calero,E.J. Alegre del Rey
El tratamiento y la calidad de vida
Fundamentos de epidemiología clínica, pp. 153-166
4.
C.D. Hepler
Práctica y formación farmacéutica para el 2010
Farm Clin, 14 (1997), pp. 127-146
5.
F. Álvarez de Toledo,P. Arcos González,L. Cabiedes Miragaya
La nueva atención farmacéutica: ¿puede la intervención farmacéutica mejorar la eficiencia terapéutica?
Rev Esp Salud Pública, 69 (1995), pp. 277-282
6.
Anónimo
El papel del farmacéutico en el sistema de atención de salud. Informe de la Organización Mundial de la Salud. Tokio, Japón, 1993
Ars Pharmaceutica, 36 (1995), pp. 285-292
7.
F. Buitrago,R. Mendoza-Espejo
Responsabilidad del médico de atención primaria en el uso racional de medicamentos
Aten Primaria, 15 (1995), pp. 137-138
8.
V. Baos Vicente
La formación del médico de familia para el uso racional de los medicamentos
Aten Primaria, 16 (1995), pp. 243-244
9.
UK Prospective Diabetes Study Group
Tigth blood presure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38
BMJ, 317 (1998), pp. 703-713
10.
M. Pahor,B.M. Psaty,C.D. Furberg
Tratamiento de los pacientes hipertensos afectados de diabetes
Lancet (ed. esp.), 33 (1998), pp. 7-8
Correspondencia: Distrito AP Bahía-Cádiz. Unidad de Farmacia. Plaza de las Tres Carabelas, 5. 11004 Cádiz. (E.J. Alegre del Rey dbahia@spa.es)
Copyright © 2001. Elsevier España, S.L.